Nasopharyngeal News and Research

RSS
Study offers new evidence of natural emission of influenza

Study offers new evidence of natural emission of influenza

arGEN-X commences ARGX-110 Phase Ib trial to treat cancer

arGEN-X commences ARGX-110 Phase Ib trial to treat cancer

Nasopharyngeal cancer patients at risk for stroke

Nasopharyngeal cancer patients at risk for stroke

Alverix receives FDA 510(k) clearance for new BD Veritor System kit

Alverix receives FDA 510(k) clearance for new BD Veritor System kit

Bacterial pathogen ‘acutely’ involved in otitis media

Bacterial pathogen ‘acutely’ involved in otitis media

Genocea raises $30M in Series C financing round

Genocea raises $30M in Series C financing round

Montelukast possible surgery alternative for obstructive sleep apnea

Montelukast possible surgery alternative for obstructive sleep apnea

The Wistar Institute, MSKCC partner to publish first annotated atlas of Epstein-Barr virus genome

The Wistar Institute, MSKCC partner to publish first annotated atlas of Epstein-Barr virus genome

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Guidebook for surgeons dealing with head and neck neoplasms

Guidebook for surgeons dealing with head and neck neoplasms

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

BioDiem signs agreement with RMIT to create new non-influenza vaccines

BioDiem signs agreement with RMIT to create new non-influenza vaccines

FDA grants 510(k) clearance for QIAGEN’s molecular detection PCR technology

FDA grants 510(k) clearance for QIAGEN’s molecular detection PCR technology

Routine 4CMenB immunizations effective against meningococcal strains in infants

Routine 4CMenB immunizations effective against meningococcal strains in infants

Blood cell therapy works for nasopharyngeal cancer: Study

Blood cell therapy works for nasopharyngeal cancer: Study

Combination of bevacizumab and chemoradiation safe, effective for nasopharyngeal carcinoma

Combination of bevacizumab and chemoradiation safe, effective for nasopharyngeal carcinoma

Six UNC faculty members named AAAC fellow

Six UNC faculty members named AAAC fellow

First large scale trial of acupuncture for prevention of xerostomia

First large scale trial of acupuncture for prevention of xerostomia

Chemotherapy plus radiation improves overall survival for patients with stage II NPC

Chemotherapy plus radiation improves overall survival for patients with stage II NPC

Dramatic rise in U.S. incidence of oropharyngeal cancer can be attributed to HPV infection

Dramatic rise in U.S. incidence of oropharyngeal cancer can be attributed to HPV infection